The hydrogen-bond: Computational approaches and applications to drug design

Annales Pharmaceutiques Francaises

Volumn 60, Issue 6, 2002, Pages 386-396

  Rey, S ^b   Carrupt, P A ^b   Testa, Bernard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NONE

Author keywords

Hydrogen bonding capacity; Molecular interaction fields; Molecular mechanics; Molecular modelling; Quantum mechanics; Structure permeation relations

Indexed keywords

AB INITIO CALCULATION; ALGORITHM; BLOOD BRAIN BARRIER; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DESIGN; DRUG PENETRATION; HYDROGEN BOND; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; QUANTUM MECHANICS;

COMPUTATIONAL BIOLOGY; DRUG DESIGN; HYDROGEN BONDING; MODELS, CHEMICAL;

EID: 0036863260     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Klemperer W. Intermolecular interactions. Science 1992; 257: 887-8.
2. Kollman P. A general analysis of noncovalent intermolecular interactions. J Am Chem Soc 1977; 99: 4875-94.
3. Williams DH. The molecular basis of biological order. Aldrichim Acta 1991; 24: 71-80.
4. Tsai RS, El Tayar N, Carrupt PA, Testa B. Physicochemical properties and transport behavior of piribedil: Considerations on its membrane-crossing potential. Int J Pharm 1992; 80: 39-49.
5. Abraham MH, Chadha HS, Mitchell RC. The factors that influence skin penetration of solutes. J Pharm Pharmacol 1995; 47: 8-16.
6. Houk J, Guy RH. Membrane models for skin penetration studies. Chem Rev 1988; 88: 455-71.
7. Pugh WJ, Hadgraft J. Ab initio prediction of human skin permeability coefficients. Int J Pharm 1994; 103: 163-78.
8. El Tayar N, Tsai RS, Testa B, Carrupt PA, Hansch C, Leo A. Percutaneous penetration of drugs: A quantitative structure-permeability relationship study. J Pharm Sci 1991; 80: 744-9.
9. Chikhale EG, Ng KY, Burton PS, Borchardt RT. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm Res 1994; 11: 412-9.
10. Testa B, El Tayar N, Altomare C, Carrupt PA, Tsai RS, Carotti A. The hydrogen bonding of drugs: Its experimental determination and role in pharmacokinetics and pharmacodynamics in Trends in Receptor Research (Angeli P, Gulini U, Quaglia W, Eds). Elsevier, Amsterdam, 1992, Vol. 18, pp. 61-72.
11. Jeffrey GA. An Introduction to Hydrogen Bonding, Oxford University Press, New York, 1997.
12. Abraham MH. Hydrogen bonding. 31. Construction of a scale of solute effective or summation hydrogen-bond basicity. J Phys Org Chem 1993; 6: 660-84.
13. Abraham MH, Chadha HS, Mitchell RC. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J Pharm Sci 1994; 83: 1257-68.
14. Raevsky OA. Hydrogen bond strength estimation by means of the HYBOT program package in computer-assisted lead finding and optimization. Current Tools for Medicinal Chemistry (van de Waterbeemd H, Testa B, Folkers G, Eds), Wiley-VHCA, Basel, 1997, pp. 367-78.
15. Scheiner S. Calculating the properties of hydrogen bonds by ab initio methods in Reviews in Computational Chemistry (Lipkowitz KB. Boyd DB, Eds), VCH Publishers, New York, 1991, Vol. 2, pp. 165-218.
16. Hehre WJ, Radom L, von Ragué Schleyer P, Pople JA. Ab Initio Molecular Orbital Theory, Wiley & Sons, New York, 1986.
17. Ford TA, Glasser L. Ab initio calculations of the structural, energetic and vibrational properties of some hydrogen bonded and van der Waals dimers. Part 3. The formaldehyde dimer. J Mol Struct (Theochem) 1997; 398: 381-94.
18. Meredith AW, Ming L, Nordholm S. Quantum chemical exploration of the HCl dimer interaction. Chem Phys 1997; 220: 63-78.
19. Nagy PI, Smith DA, Alagona G, Ghio C. Ab initio Studies of free and monohydrated carboxylic acids in the gas phase. J Phys Chem 1994; 98: 486-93.
20. Rodham DA, Suzuki S, Suenram RD, Lovas FJ, Dasgupta S, Goddard III WA et al. Hydrogen bonding in the benzene-ammonia dimer. Nature 1993; 362: 735-7.
21. Scheiner S. Ab initio studies of hydrogen bonds: The water dimer paradigm. Annu Rev Phys Chem 1994; 45: 23-56.
22. Singh UC, Kollman PA. A water dimer potential based on ab initio calculations using Morokuma component analyses. J Chem Phys 1985; 83: 4033-40.
23. Tachikawa H, Ogasawara M. Ab initio molecular orbital study on water dimer anions. J Phys Chem 1990; 94: 1746-50.
24. 2 hydrogen bonded complex. J Mol Struct (Theochem) 1998; 452: 55-66.
25. 2 a density functional and ab initio study. J Mol Struct (Theochem) 1998; 427: 39-53.
26. Murray JS, Ranganathan S, Politzer P. Correlations between the solvent hydrogen bond acceptor parameter β and the molecular electrostatic potential. J Org Chem 1991; 56: 3734-7.
27. Hagelin H, Murray JS, Brinck T, Berthelot M, Politzer P. Family-independent relationships between computed molecular surface quantities and solute hydrogen bond acidity/basicity and solute-induced methanol O-H infrared frequency shifts. Can J Chem 1995; 73: 483-8.
28. Sjoberg P. MOLSURF - A generator of chemical descriptors for QSAR in computer-assisted lead finding and optimization. Current Tools for Medicinal Chemistry (van de Waterbeemd H, Testa B, Folkers G, Eds) Wiley-VCH, Weinheim, 1997, pp. 81-92.
29. Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP. AM1: A new general purpose quantum mechanical molecular model. J Am Chem Soc 1985; 107: 3902-9.
30. Zerner MC. Semiempirical molecular orbital methods in Reviews in Computational Chemistry (Lipkowitz KB, Boyd DB, Eds), VCH Publishers, New York, 1991, Vol. 2, pp. 313-65.
31. Stewart JJP. Semiempirical molecular orbital methods in Reviews in Computational Chemistry (Lipkowitz KB, Boyd DB, Eds), VCH Publishers, New York, 1990, Vol. 1, pp. 45-81.
32. Gancia E, Montana JG, Manallack D. Theoretical hydrogen bonding parameters for drug design. J Mol Graphics Model 2001; 19: 349-62.
33. Wilson LY, Famini GR. Using theoretical descriptors in quantitative structure-activity relationships: Some toxicological indices. J Med Chem 1991; 34: 1668-74.
34. Lowrey AH, Cramer CJ, Urban JJ, Famini GR. Quantum chemical descriptors for linear solvation energy relationships. Comput Chem 1995; 19: 209-15.
35. DeKock RL, Madura JD, Rioux F, Casanova J. Computational chemistry in the undergraduate curriculum in Reviews in Computational Chemistry (Lipkowitz KB, Boyd DB, Eds), VCH Publishers, New York, 1993, Vol. 4, pp. 149-228.
36. Clark M, Cramer III RD, Van Opdenbosch N. Validation of the general purpose Tripos 5.2 force field. J Comput Chem 1989; 10: 982-1012.
37. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G et al. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106: 765-84.
38. Weiner SJ, Kollman PA, Nguyen DT, Case DA. An all atoms force field for simulation of proteins and nucleic acids. J Comput Chem 1986; 7: 230-52.
39. Singh UC, Weiner PK, Kollman P. AMBER 3.0. University of California, San Francisco 1986.
40. Halgren TA. MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular interaction energies and geometries. J Comput Chem 1999; 20: 730-48.
41. Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 1999; 20: 720-9.
42. Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996; 118: 11225-36.
43. van Gunsteren WF, Berendsen HJC. Computer simulation of molecular dynamics: Methodology, applications, and perspectives in chemistry. Angew Chem Int Ed Engl 1994; 29: 992-1022.
44. Brooks BR, Bruccoleri RE, Olafson BD, States DJ. Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983; 4: 187-217.
45. Wade RC, Goodford PJ. Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds. J Med Chem 1993; 36: 148-56.
46. 46.Wade RC, Clark KJ, Goodford PJ. Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds. J Med Chem 1993; 36: 140-7.
47. Boobbyer DNA, Goodford PJ, McWhinnie PM, Wade RC. New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure. J Med Chem 1989; 32: 1083-94.
48. Palm K, Stenberg P, Luthman K, Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res 1997; 14: 568-71.
49. Platts JA, Butina D, Abraham MH, Hersey A. Estimation of molecular linear free energy relation descriptors using a group contribution approach. J Chem Inf Comput Sci 1999; 39: 835-45.
50. Rey S, Caron G, Ermondi G, Gaillard P, Pagliara A, Carrupt PA et al. Development of molecular hydrogen bonding potentials (MHBPs) and their application to structure permeation relations. J Mol Graphics Model 2001; 19: 521-35.
51. Carrupt PA, El Tayar N, Karlen A, Testa B. Molecular electrostatic potentials for characterizing drug-biosystem interactions. Methods Enzymol 1991; 203: 638-77.
52. Goodford PJ. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. JMed Chem 1985; 28: 849-57.
53. Gaillard P, Carrupt PA, Testa B, Boudon A. Molecular lipophilicity potential, a tool in 3D-QSAR. Method and applications. J Comput-Aided Mol Design 1994; 8: 83-96.
54. Carrupt PA, Gaillard P, Billois F, Weber P, Testa B, Meyer C et al. The molecular lipophilicity potential (MLP): A new tool for log P calculations and docking, and in comparative molecular field analysis (CoMFA) in Lipophilicity in Drug Action and Toxicology (Pliska V, Testa B, van de Waterbeemd H, Eds), VCH Publishers, Weinheim, 1996, pp. 195-217.
55. 1A receptor: Contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-activity relationship models. J Med Chem 1996; 39: 126-34.
56. Gaillard P, Carrupt PA, Testa B. The conformational- dependent lipophilicity of morphine glucuronides as calculated from their molecular lipophilicity potential. Bioorg Med Chem Lett 1994; 4: 737-42.
57. Cruciani G, Pastor M, Guba W. VolSurf: A new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 2002; 11: S29-S39.